A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection
Published inClinical infectious diseases, vol. 39, no. 9, p. 1285-1292
Publication date2004
Abstract
Keywords
- Administration, Oral
- Adult
- Aged
- Bacteremia/drug therapy
- Catheters, Indwelling/microbiology
- Drug Therapy, Combination
- Female
- Fleroxacin/administration & dosage/adverse effects/ therapeutic use
- Floxacillin/administration & dosage/adverse effects/ therapeutic use
- Humans
- Male
- Methicillin Resistance/drug effects
- Middle Aged
- Prospective Studies
- Rifampin/administration & dosage/adverse effects/ therapeutic use
- Safety
- Staphylococcal Infections/diagnosis/ drug therapy/metabolism
- Staphylococcus/drug effects/isolation & purification
- Staphylococcus aureus/drug effects/isolation & purification
- Treatment Outcome
- Vancomycin/administration & dosage/adverse effects/ therapeutic use
Affiliation
Citation (ISO format)
SCHRENZEL, Jacques et al. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection. In: Clinical infectious diseases, 2004, vol. 39, n° 9, p. 1285–1292. doi: 10.1086/424506
Main files (1)
Article
Identifiers
- PID : unige:7578
- DOI : 10.1086/424506
- PMID : 15494904
ISSN of the journal1058-4838